AstraZeneca's Ultomiris Poised for Accelerated Approval in IgA Nephropathy After Striking Trial Results
A Triumph of Advocacy: Manitoba Man with Rare Disease Secures Life-Saving Drug Coverage
European Experts Back Two AstraZeneca Breakthroughs: New Hope for Rare Diseases